Limits...
Clinical studies of the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.

Makino H, Sada KE - Clin. Exp. Nephrol. (2013)

Bottom Line: In Japan, the Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare, has been promoting basic and clinical research on vasculitis since 1972.The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator: Basic and Pathological Research Subcommittee, Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis, Clinical Research Subcommittee of Large-sized Vessel Vasculitis, and International Cooperation Research Subcommittee.Since 2008, 9 nationwide clinical studies for vasculitis have been conducted and 8 clinical and basic studies are in progress.

View Article: PubMed Central - PubMed

Affiliation: Principal Investigator of the Research Committee on Intractable Vasculitides, The Ministry of Health, Labour and Welfare of Japan, Tokyo, Japan, makino@md.okayama-u.ac.jp.

ABSTRACT
In Japan, the Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare, has been promoting basic and clinical research on vasculitis since 1972. The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator: Basic and Pathological Research Subcommittee, Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis, Clinical Research Subcommittee of Large-sized Vessel Vasculitis, and International Cooperation Research Subcommittee. Since 2008, 9 nationwide clinical studies for vasculitis have been conducted and 8 clinical and basic studies are in progress.

Show MeSH

Related in: MedlinePlus

Overview of the tasks of the Research Committee on Intractable Vasculitides. CRF case report form, ANCA antineutrophil cytoplasmic antibody, AAV ANCA-associated vasculitis, DCVAS Diagnostic and Classification Criteria in Vasculitis Study, PEXIVAS plasma exchange and glucocorticoid dosing in the treatment of ANCA-associated vasculitides, RemIT-JAV-RPGN prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides and rapidly progressive glomerulonephritis, Co-RemIT-JAV observational cohort study of remission maintenance therapy in Japanese patients with ANCA-associated vasculitis, RemIT-JAV prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides
© Copyright Policy - OpenAccess
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3824225&req=5

Fig1: Overview of the tasks of the Research Committee on Intractable Vasculitides. CRF case report form, ANCA antineutrophil cytoplasmic antibody, AAV ANCA-associated vasculitis, DCVAS Diagnostic and Classification Criteria in Vasculitis Study, PEXIVAS plasma exchange and glucocorticoid dosing in the treatment of ANCA-associated vasculitides, RemIT-JAV-RPGN prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides and rapidly progressive glomerulonephritis, Co-RemIT-JAV observational cohort study of remission maintenance therapy in Japanese patients with ANCA-associated vasculitis, RemIT-JAV prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides

Mentions: The Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare of Japan, has conducted and promoted basic and clinical research on vasculitis since 1972. We study 9 diseases: Takayasu arteritis, temporal arteritis, polyarteritis nodosa, Buerger disease, microscopic polyangiitis, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, antiphospholipid syndrome, and rheumatoid vasculitis. Experts from several fields including nephrology, rheumatology, pulmonology, dermatology, cardiology, vascular surgery, pathology, epidemiology, and otorhinolaryngology work cooperatively. The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator (Hirofumi Makino):Basic and Pathological Research Subcommittee of Vasculitis Syndrome (Yasunori Okada), Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis Syndrome (Yoshihiro Arimura), Clinical Research Subcommittee of Large-sized Vessel Vasculitis Syndrome (Kazuo Tanemoto), and International Cooperation Research Subcommittee of Vasculitis Syndrome (Kazuo Suzuki, Shoichi Fujimoto) (Fig. 1).Fig. 1


Clinical studies of the Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.

Makino H, Sada KE - Clin. Exp. Nephrol. (2013)

Overview of the tasks of the Research Committee on Intractable Vasculitides. CRF case report form, ANCA antineutrophil cytoplasmic antibody, AAV ANCA-associated vasculitis, DCVAS Diagnostic and Classification Criteria in Vasculitis Study, PEXIVAS plasma exchange and glucocorticoid dosing in the treatment of ANCA-associated vasculitides, RemIT-JAV-RPGN prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides and rapidly progressive glomerulonephritis, Co-RemIT-JAV observational cohort study of remission maintenance therapy in Japanese patients with ANCA-associated vasculitis, RemIT-JAV prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3824225&req=5

Fig1: Overview of the tasks of the Research Committee on Intractable Vasculitides. CRF case report form, ANCA antineutrophil cytoplasmic antibody, AAV ANCA-associated vasculitis, DCVAS Diagnostic and Classification Criteria in Vasculitis Study, PEXIVAS plasma exchange and glucocorticoid dosing in the treatment of ANCA-associated vasculitides, RemIT-JAV-RPGN prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides and rapidly progressive glomerulonephritis, Co-RemIT-JAV observational cohort study of remission maintenance therapy in Japanese patients with ANCA-associated vasculitis, RemIT-JAV prospective cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitides
Mentions: The Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare of Japan, has conducted and promoted basic and clinical research on vasculitis since 1972. We study 9 diseases: Takayasu arteritis, temporal arteritis, polyarteritis nodosa, Buerger disease, microscopic polyangiitis, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, antiphospholipid syndrome, and rheumatoid vasculitis. Experts from several fields including nephrology, rheumatology, pulmonology, dermatology, cardiology, vascular surgery, pathology, epidemiology, and otorhinolaryngology work cooperatively. The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator (Hirofumi Makino):Basic and Pathological Research Subcommittee of Vasculitis Syndrome (Yasunori Okada), Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis Syndrome (Yoshihiro Arimura), Clinical Research Subcommittee of Large-sized Vessel Vasculitis Syndrome (Kazuo Tanemoto), and International Cooperation Research Subcommittee of Vasculitis Syndrome (Kazuo Suzuki, Shoichi Fujimoto) (Fig. 1).Fig. 1

Bottom Line: In Japan, the Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare, has been promoting basic and clinical research on vasculitis since 1972.The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator: Basic and Pathological Research Subcommittee, Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis, Clinical Research Subcommittee of Large-sized Vessel Vasculitis, and International Cooperation Research Subcommittee.Since 2008, 9 nationwide clinical studies for vasculitis have been conducted and 8 clinical and basic studies are in progress.

View Article: PubMed Central - PubMed

Affiliation: Principal Investigator of the Research Committee on Intractable Vasculitides, The Ministry of Health, Labour and Welfare of Japan, Tokyo, Japan, makino@md.okayama-u.ac.jp.

ABSTRACT
In Japan, the Research Committee on Intractable Vasculitides, supported by the Ministry of Health, Labour and Welfare, has been promoting basic and clinical research on vasculitis since 1972. The present Research Committee on Intractable Vasculitides comprises 4 subcommittees under the direction of a Principal Investigator: Basic and Pathological Research Subcommittee, Clinical Research Subcommittee of Small and Medium-sized Vessel Vasculitis, Clinical Research Subcommittee of Large-sized Vessel Vasculitis, and International Cooperation Research Subcommittee. Since 2008, 9 nationwide clinical studies for vasculitis have been conducted and 8 clinical and basic studies are in progress.

Show MeSH
Related in: MedlinePlus